1. Home
  2. MTA vs BME Comparison

MTA vs BME Comparison

Compare MTA & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalla Royalty & Streaming Ltd.

MTA

Metalla Royalty & Streaming Ltd.

N/A

Current Price

$9.82

Market Cap

636.3M

Sector

N/A

ML Signal

N/A

Logo Blackrock Health Sciences Trust

BME

Blackrock Health Sciences Trust

N/A

Current Price

$45.69

Market Cap

593.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
MTA
BME
Founded
1983
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
636.3M
593.0M
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
MTA
BME
Price
$9.82
$45.69
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
579.7K
41.0K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$81.63
N/A
Revenue Next Year
$62.44
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.25
$35.95
52 Week High
$11.60
$46.43

Technical Indicators

Market Signals
Indicator
MTA
BME
Relative Strength Index (RSI) 56.81 61.73
Support Level $6.35 $39.51
Resistance Level $11.60 $46.43
Average True Range (ATR) 0.50 0.50
MACD -0.13 -0.07
Stochastic Oscillator 43.17 65.62

Price Performance

Historical Comparison
MTA
BME

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company that engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests. Geographically, the company generates revenue from Australia, Brazil, Mexico, and the USA, with the majority generated from Brazil.

About BME Blackrock Health Sciences Trust

Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.

Share on Social Networks: